Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hans G Drexler
BCR-ABL1-independent PI3Kinase Activation Causing Imatinib-Resistance
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
SET-NUP214 Fusion in Acute Myeloid Leukemia- And T-Cell Acute Lymphoblastic Leukemia-Derived Cell Lines
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Related publications
BCR-ABL1 and Beyond
Pathology
Forensic Medicine
Pathology
The Use of Imatinib Resistance Mutation Analysis to Direct Therapy in Philadelphia Chromosome/BCR-Abl1 Positive Chronic Myeloid Leukaemia Patients Failing Imatinib Treatment, in Patan Hospital, Nepal
British Journal of Haematology
Hematology
Reactive Oxygen Species and Mitochondrial DNA Damage and Repair in BCR-ABL1 Cells Resistant to Imatinib
BioResearch Open Access
Biochemistry
Genetics
Molecular Biology
Imatinib Mesylate Resistance Through BCR-ABL Independence in Chronic Myelogenous Leukemia
Cancer Research
Cancer Research
Oncology
A Non-Atp-Competitive Inhibitor of BCR-ABL Overrides Imatinib Resistance
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
BCR-ABL1 Mutations in Patients With Imatinib-Resistant Philadelphia Chromosome-Positive Leukemia by Use of the PCR-Invader Assay
Leukemia Research
Cancer Research
Oncology
Hematology
Semi‑random Mutagenesis Profile of BCR‑ABL During Imatinib Resistance Acquirement in K562 Cells
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Predictive Value of MRD in Ph+ ALL Treated With Imatinib in the EsPhALL Study, Based on IG/TR and BCR/ABL1 Methodologies
Haematologica
Hematology
Modelling Ponatinib Resistance in Tyrosine Kinase Inhibitor-Naïve and Dasatinib Resistant BCR-ABL1+ Cell Lines
Oncotarget
Oncology
